Edward Stadtmauer, MD, leads study that shows drug combination is effective for multiple myeloma

December 1, 2008

VIV News

Edward A. Stadtmauer, MD, Director of the Abramson Cancer Center Bone Marrow and Stem Cell Transplant Program and lead investigator from Penn, was part of the U.S. study published in the New England Journal of Medicine alongside a companion study from Europe showing similar results ... read more

To learn more about clinical trials at Penn's Abramson Cancer Center click here or call 1-800-789-PENN (7366).